Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony P Adamis

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Retina (Philadelphia, Pa.)|February 4, 2005
The role of vascular endothelial growth factor in ocular health and diseaseAnthony P Adamis, David T Shima
Current Opinion in Ophthalmology|March 10, 2022
Development of the Port Delivery System with ranibizumab for neovascular age-related macular degenerationAnthony P Adamis, Eugene de Juan
Annals of the New York Academy of Sciences|December 6, 2006
Anti-VEGF aptamer (pegaptanib) therapy for ocular vascular diseasesEugene W M Ng, Anthony P Adamis
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|June 11, 2005
Targeting angiogenesis, the underlying disorder in neovascular age-related macular degenerationEugene W M Ng, Anthony P Adamis
The New England Journal of Medicine|July 30, 2015
Targeting the Effect of VEGF in Diabetic Macular EdemaAnthony P Adamis, Jason Ehrlich, Anne Fung
Developments in Ophthalmology|January 25, 2007
Vascular endothelial growth factor and the potential therapeutic use of pegaptanib (macugen) in diabetic retinopathyCarla Starita, Manju Patel, Barrett Katz, et al.
Ophthalmology Clinics of North America|June 18, 2002
Mechanisms of age-related macular degenerationDeeba Husain, Balamurali Ambati, Anthony P Adamis, et al.
Eye (London, England)|June 17, 2020
Building on the success of anti-vascular endothelial growth factor therapy: a vision for the next decadeAnthony P Adamis, Christopher J Brittain, Atul Dandekar, et al.
Survey of Ophthalmology|May 15, 2003
Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategiesJayakrishna Ambati, Balamurali K Ambati, Sonia H Yoo, et al.
Cornea|June 27, 2003
Inhibition of corneal neovascularization by genetic ablation of CCR2Balamurali K Ambati, Antonia M Joussen, William A Kuziel, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Retina (Philadelphia, Pa.)|February 4, 2005
The role of vascular endothelial growth factor in ocular health and diseaseAnthony P Adamis, David T Shima
Current Opinion in Ophthalmology|March 10, 2022
Development of the Port Delivery System with ranibizumab for neovascular age-related macular degenerationAnthony P Adamis, Eugene de Juan
Annals of the New York Academy of Sciences|December 6, 2006
Anti-VEGF aptamer (pegaptanib) therapy for ocular vascular diseasesEugene W M Ng, Anthony P Adamis
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|June 11, 2005
Targeting angiogenesis, the underlying disorder in neovascular age-related macular degenerationEugene W M Ng, Anthony P Adamis
The New England Journal of Medicine|July 30, 2015
Targeting the Effect of VEGF in Diabetic Macular EdemaAnthony P Adamis, Jason Ehrlich, Anne Fung
Developments in Ophthalmology|January 25, 2007
Vascular endothelial growth factor and the potential therapeutic use of pegaptanib (macugen) in diabetic retinopathyCarla Starita, Manju Patel, Barrett Katz, et al.
Ophthalmology Clinics of North America|June 18, 2002
Mechanisms of age-related macular degenerationDeeba Husain, Balamurali Ambati, Anthony P Adamis, et al.
Eye (London, England)|June 17, 2020
Building on the success of anti-vascular endothelial growth factor therapy: a vision for the next decadeAnthony P Adamis, Christopher J Brittain, Atul Dandekar, et al.
Survey of Ophthalmology|May 15, 2003
Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategiesJayakrishna Ambati, Balamurali K Ambati, Sonia H Yoo, et al.
Cornea|June 27, 2003
Inhibition of corneal neovascularization by genetic ablation of CCR2Balamurali K Ambati, Antonia M Joussen, William A Kuziel, et al.
Pageof 7